ADC Therapeutics SA (ADCT)

ADC Therapeutics Revenue

ADC Therapeutics had revenue of $18.46M in the quarter ending September 30, 2024, with 27.40% growth. This brings the company's revenue in the last twelve months to $70.72M, down -42.30% year-over-year. In the year 2023, ADC Therapeutics had annual revenue of $69.56M, down -66.86%.

• Revenue (ttm): $70.72M
• Revenue Growth: -42.30%
• P/S Ratio: 2.56
• Revenue / Employee: $258,091
• Employees: 274
• Market Cap: 192.41M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	69.56M	-140.35M	-66.86%
Dec 31, 2022	209.91M	175.99M	518.89%
Dec 31, 2021	33.92M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	2.34M	1.20M	105.26%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.